feed,title,long_url,short_url
SeekingAlpha,"MAT, ENDP and PALI among pre market gainers",https://seekingalpha.com/news/3756583,
SeekingAlpha,Humanigen announces plans to start phase 1b study of ifabotuzumab in solid tumors,https://seekingalpha.com/news/3756581,
